| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: Meta-analysis of randomized controlled trials
|
Zhang, Haoran
|
|
2012
|
36 |
4 |
p. 431-437
7 p.
|
artikel
|
| 2 |
A novel recurrent translocation t(7;17)(q22;p13) and a late-appearing t(2;3)(p13;q26.2) with dysmegakaryopoiesis in acute myeloid leukemia
|
Yamamoto, Katsuya
|
|
2012
|
36 |
4 |
p. e84-e86
nvt p.
|
artikel
|
| 3 |
A rare cryptic and complex rearrangement leading to MLL-MLLT10 gene fusion masked by del(10)(p12) in a child with acute monoblastic leukemia (AML-M5)
|
de Figueiredo, Amanda Faria
|
|
2012
|
36 |
4 |
p. e74-e77
nvt p.
|
artikel
|
| 4 |
Are low-intensity induction strategies better for older patients with acute myeloid leukemia?
|
Roboz, Gail J.
|
|
2012
|
36 |
4 |
p. 407-412
6 p.
|
artikel
|
| 5 |
A tribute to Professor Terence “Terry” John Hamblin
|
Bennett, John M.
|
|
2012
|
36 |
4 |
p. 383-384
2 p.
|
artikel
|
| 6 |
Azacitidine in a patient with newly diagnosed acute myeloid leukemia and poor risk cytogenetics: Outcomes of prolonged therapy
|
Pappa, Vasiliki
|
|
2012
|
36 |
4 |
p. e78-e80
nvt p.
|
artikel
|
| 7 |
AZA-ESA combo: A new standard for higher risk MDS?
|
Mittelman, Moshe
|
|
2012
|
36 |
4 |
p. 389-391
3 p.
|
artikel
|
| 8 |
Cardamonin exerts potent activity against multiple myeloma through blockade of NF-κB pathway in vitro
|
Qin, You
|
|
2012
|
36 |
4 |
p. 514-520
7 p.
|
artikel
|
| 9 |
Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemia
|
Ottone, T.
|
|
2012
|
36 |
4 |
p. 474-478
5 p.
|
artikel
|
| 10 |
Comparison between multiparameter flow cytometry and WT1-RNA quantification in monitoring minimal residual disease in acute myeloid leukemia without specific molecular targets
|
Rossi, Giovanni
|
|
2012
|
36 |
4 |
p. 401-406
6 p.
|
artikel
|
| 11 |
Cytarabine in relapsed acute myeloid leukemia
|
Hardesty, Brandon M.
|
|
2012
|
36 |
4 |
p. 387-388
2 p.
|
artikel
|
| 12 |
Differential diagnosis of paediatric bone pain: Acute lymphoblastic leukemia
|
van der Have, Nicolien
|
|
2012
|
36 |
4 |
p. 521-523
3 p.
|
artikel
|
| 13 |
Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?
|
Itzykson, R.
|
|
2012
|
36 |
4 |
p. 397-400
4 p.
|
artikel
|
| 14 |
Editorial Board
|
|
|
2012
|
36 |
4 |
p. CO2-
1 p.
|
artikel
|
| 15 |
Elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, and idarubicin combination is active in refractory acute myeloid leukemia
|
Giles, Francis
|
|
2012
|
36 |
4 |
p. e71-e73
nvt p.
|
artikel
|
| 16 |
Fludarabine and a histone deacetylase inhibitor – Strange bedfellows
|
Prince, H. Miles
|
|
2012
|
36 |
4 |
p. 385-386
2 p.
|
artikel
|
| 17 |
Glycogen synthase kinase-3 (GSK-3) inhibition induces apoptosis in leukemic cells through mitochondria-dependent pathway
|
Mirlashari, Mohammad Reza
|
|
2012
|
36 |
4 |
p. 499-508
10 p.
|
artikel
|
| 18 |
Health-related quality of life of bosutinib (SKI-606) in imatinib-resistant or imatinib-intolerant chronic phase chronic myeloid leukemia
|
Trask, Peter C.
|
|
2012
|
36 |
4 |
p. 438-442
5 p.
|
artikel
|
| 19 |
Hypomethylating therapy and autoimmunity in MDS: An enigmatic relationship
|
Kotsianidis, Ioannis
|
|
2012
|
36 |
4 |
p. e90-e92
nvt p.
|
artikel
|
| 20 |
Immune-mediated peripheral neuropathy occurring simultaneously with recurrent graft-versus-host disease after allogenic hematopoietic stem cell transplantation
|
Doi, Yukiko
|
|
2012
|
36 |
4 |
p. e63-e65
nvt p.
|
artikel
|
| 21 |
Implementation of flow cytometry in the diagnostic work-up of myelodysplastic syndromes in a multicenter approach: Report from the Dutch Working Party on Flow Cytometry in MDS
|
Westers, Theresia M.
|
|
2012
|
36 |
4 |
p. 422-430
9 p.
|
artikel
|
| 22 |
Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia
|
Langabeer, Stephen E.
|
|
2012
|
36 |
4 |
p. 483-484
2 p.
|
artikel
|
| 23 |
Lack of somatic mutations in the catalytic domains of CREBBP and EP300 genes implies a role for histone deacetylase inhibition in myeloproliferative neoplasms
|
Andersen, Christen Lykkegaard
|
|
2012
|
36 |
4 |
p. 485-487
3 p.
|
artikel
|
| 24 |
LBH-589 (panobinostat) potentiates fludarabine anti-leukemic activity through a JNK- and XIAP-dependent mechanism
|
Rosato, Roberto
|
|
2012
|
36 |
4 |
p. 491-498
8 p.
|
artikel
|
| 25 |
Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia
|
Trifilio, Steven M.
|
|
2012
|
36 |
4 |
p. 394-396
3 p.
|
artikel
|
| 26 |
Nilotinib-mediated increase in fasting glucose level is reversible, does not convert to type 2 diabetes and is likely correlated with increased body mass index
|
Breccia, Massimo
|
|
2012
|
36 |
4 |
p. e66-e67
nvt p.
|
artikel
|
| 27 |
N-terminally truncated WT1 variant (sWT1) is expressed at very low levels in acute myeloid leukemia and advanced phases of chronic myeloid leukemia
|
Lopotová, Tereza
|
|
2012
|
36 |
4 |
p. e81-e83
nvt p.
|
artikel
|
| 28 |
Older patients with normal karyotype acute myeloid leukemia have a higher rate of genomic changes compared to young patients as determined by SNP array analysis
|
Koren-Michowitz, Maya
|
|
2012
|
36 |
4 |
p. 467-473
7 p.
|
artikel
|
| 29 |
PDS5A, a novel translocation partner of MLL in acute myeloid leukemia
|
Put, Natalie
|
|
2012
|
36 |
4 |
p. e87-e89
nvt p.
|
artikel
|
| 30 |
Prognostic implications of leg ulcers from hydroxycarbamide therapy in patients with essential thrombocythaemia
|
Francis, Sebastian
|
|
2012
|
36 |
4 |
p. 488-490
3 p.
|
artikel
|
| 31 |
Rare tetraploidy with large 5q deletion in acute myeloid leukemia with myelodysplasia-related changes (AML-MRC)
|
Jarosova, Marie
|
|
2012
|
36 |
4 |
p. e68-e70
nvt p.
|
artikel
|
| 32 |
Sequential array comparative genomic hybridization analysis identifies copy number changes during blastic transformation of chronic myeloid leukemia
|
Lee, Seung-Tae
|
|
2012
|
36 |
4 |
p. 418-421
4 p.
|
artikel
|
| 33 |
SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia
|
Mauro, Francesca Romana
|
|
2012
|
36 |
4 |
p. 459-466
8 p.
|
artikel
|
| 34 |
The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP
|
Castillo, Jorge J.
|
|
2012
|
36 |
4 |
p. 413-417
5 p.
|
artikel
|
| 35 |
The hematopoietic cell transplantation comorbidity index is a predictor of early death and survival in adult acute myeloid leukemia patients
|
Savic, Aleksandar
|
|
2012
|
36 |
4 |
p. 479-482
4 p.
|
artikel
|
| 36 |
The minimal residual disease concept coming of age – Now for the direct comparison of methodologies
|
Ommen, Hans Beier
|
|
2012
|
36 |
4 |
p. 392-393
2 p.
|
artikel
|
| 37 |
The study of resistant mechanisms and reversal in an imatinib resistant Ph+ acute lymphoblastic leukemia cell line
|
Xing, Hongyun
|
|
2012
|
36 |
4 |
p. 509-513
5 p.
|
artikel
|
| 38 |
The utility of fluorescence in situ hybridization analysis in diagnosing myelodysplastic syndromes is limited to cases with karyotype failure
|
Jiang, Hui
|
|
2012
|
36 |
4 |
p. 448-452
5 p.
|
artikel
|
| 39 |
Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL)
|
Molica, Stefano
|
|
2012
|
36 |
4 |
p. 443-447
5 p.
|
artikel
|
| 40 |
WT1 expression as a marker of minimal residual disease predicts outcome in acute myeloid leukemia when measured post-consolidation
|
Gray, James X.
|
|
2012
|
36 |
4 |
p. 453-458
6 p.
|
artikel
|
Tijdschrift beschrijving